Loading…

Oral tolerance as therapy for experimental autoimmune encephalomyelitis and multiple sclerosis: Demonstration of T cell anergy

Experimental autoimmune encephalomyelitis (EAE) is an important model for developing therapies for multiple sclerosis (MS). The oral administration of the central nervous system antigen, myelin basic protein (MBP), to Lewis rats and susceptible mouse strains prior to MBP immunization prevents the in...

Full description

Saved in:
Bibliographic Details
Published in:Immunology and cell biology 1998-02, Vol.76 (1), p.74-82
Main Authors: Jewell, Scott D, Gienapp, Ingrid E, Cox, Karen L, Whitacre, Caroline C
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3979-a1d9768008cf0f0da047ce5eabc5551ca08ecdc35579444be5cbdb5cc282dbd33
cites cdi_FETCH-LOGICAL-c3979-a1d9768008cf0f0da047ce5eabc5551ca08ecdc35579444be5cbdb5cc282dbd33
container_end_page 82
container_issue 1
container_start_page 74
container_title Immunology and cell biology
container_volume 76
creator Jewell, Scott D
Gienapp, Ingrid E
Cox, Karen L
Whitacre, Caroline C
description Experimental autoimmune encephalomyelitis (EAE) is an important model for developing therapies for multiple sclerosis (MS). The oral administration of the central nervous system antigen, myelin basic protein (MBP), to Lewis rats and susceptible mouse strains prior to MBP immunization prevents the induction of EAE. Clinical trials administering myelin orally to MS patients have met with only partial success, and thus require that oral tolerance be further studied to improve this treatment strategy. Clonal anergy, clonal deletion, immune deviation from Th1 to Th2 T cell subsets, and active suppression by TGF‐β‐secreting T cells have all been implicated as possible mechanisms in oral tolerance. Which mechanism predominates depends on antigen dosage, frequency of feeding, and timing of antigen administration. In this study, we have characterized T cells derived from MBP‐fed rats and determined the level of their unresponsiveness. Myelin basic protein‐specific T cells are indeed present although in reduced numbers in lymphoid tissue of orally tolerized animals. Following several cell divisions in the presence of IL‐2, these MBP‐specific T cells undergo a dramatic reversal of unresponsiveness, proliferate in response to MBP and are capable of transferring EAE. These results support clonal anergy as an important mechanism for oral tolerance. Recent developments in clinical trials of oral tolerance are described.
doi_str_mv 10.1046/j.1440-1711.1998.00716.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79809365</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79809365</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3979-a1d9768008cf0f0da047ce5eabc5551ca08ecdc35579444be5cbdb5cc282dbd33</originalsourceid><addsrcrecordid>eNqNkcFu3CAQhlHVKN2kfYRKnHqzC4sx0EvVbts0UqJckjPCeNywwsY1WFlf-uzB3VWu7QnEfPMz8CGEKSkpqeqP-5JWFSmooLSkSsmSEEHr8vAKbV4Kr9GGSCoLVVf0DbqIcU8ytZXsHJ0rzpkQaoP-3E3G4xQ8TGawgE3E6THvxwV3YcJwGGFyPQwpU2ZOwfX9PACGzI6Pxod-Ae-Si9gMLe5nn9zoAUeb80J08RP-Bn0YYppMcmHAocP32ILPYQNMv5a36KwzPsK703qJHn58v9_9LG7urq53X24Ky5RQhaGtErUkRNqOdKQ1pBIWOJjGcs6pNUSCbS3jXKiqqhrgtmkbbu1WbtumZewSfTjmjlP4PUNMundxnSOPEeaohZJEsZr_E6Q1E4opmUF5BG1-aJyg02P-KDMtmhK9OtJ7varQqwq9OtJ_HelDbn1_umNuemhfGk9Scv3zsf7kPCz_nauvb3df1wPFngGJ6qRX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16379398</pqid></control><display><type>article</type><title>Oral tolerance as therapy for experimental autoimmune encephalomyelitis and multiple sclerosis: Demonstration of T cell anergy</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Jewell, Scott D ; Gienapp, Ingrid E ; Cox, Karen L ; Whitacre, Caroline C</creator><creatorcontrib>Jewell, Scott D ; Gienapp, Ingrid E ; Cox, Karen L ; Whitacre, Caroline C</creatorcontrib><description>Experimental autoimmune encephalomyelitis (EAE) is an important model for developing therapies for multiple sclerosis (MS). The oral administration of the central nervous system antigen, myelin basic protein (MBP), to Lewis rats and susceptible mouse strains prior to MBP immunization prevents the induction of EAE. Clinical trials administering myelin orally to MS patients have met with only partial success, and thus require that oral tolerance be further studied to improve this treatment strategy. Clonal anergy, clonal deletion, immune deviation from Th1 to Th2 T cell subsets, and active suppression by TGF‐β‐secreting T cells have all been implicated as possible mechanisms in oral tolerance. Which mechanism predominates depends on antigen dosage, frequency of feeding, and timing of antigen administration. In this study, we have characterized T cells derived from MBP‐fed rats and determined the level of their unresponsiveness. Myelin basic protein‐specific T cells are indeed present although in reduced numbers in lymphoid tissue of orally tolerized animals. Following several cell divisions in the presence of IL‐2, these MBP‐specific T cells undergo a dramatic reversal of unresponsiveness, proliferate in response to MBP and are capable of transferring EAE. These results support clonal anergy as an important mechanism for oral tolerance. Recent developments in clinical trials of oral tolerance are described.</description><identifier>ISSN: 0818-9641</identifier><identifier>EISSN: 1440-1711</identifier><identifier>DOI: 10.1046/j.1440-1711.1998.00716.x</identifier><identifier>PMID: 9553779</identifier><language>eng</language><publisher>United States: Nature Publishing Group</publisher><subject>Administration, Oral ; anergy ; Animals ; Cells, Cultured ; Clonal Anergy - immunology ; Cytokines - secretion ; Encephalomyelitis, Autoimmune, Experimental - immunology ; experimental autoimmune encephalomyelitis ; Female ; Guinea Pigs ; Immune Tolerance - immunology ; Male ; multiple sclerosis ; Multiple Sclerosis - immunology ; Myelin Basic Protein - administration &amp; dosage ; Myelin Basic Protein - immunology ; oral tolerance ; Phenotype ; Rats ; Rats, Inbred Lew ; T cell ; T-Lymphocytes - immunology ; T-Lymphocytes - secretion ; Tuberculin - administration &amp; dosage ; Tuberculin - immunology</subject><ispartof>Immunology and cell biology, 1998-02, Vol.76 (1), p.74-82</ispartof><rights>1998 Australasian Society for Immunology Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3979-a1d9768008cf0f0da047ce5eabc5551ca08ecdc35579444be5cbdb5cc282dbd33</citedby><cites>FETCH-LOGICAL-c3979-a1d9768008cf0f0da047ce5eabc5551ca08ecdc35579444be5cbdb5cc282dbd33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9553779$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jewell, Scott D</creatorcontrib><creatorcontrib>Gienapp, Ingrid E</creatorcontrib><creatorcontrib>Cox, Karen L</creatorcontrib><creatorcontrib>Whitacre, Caroline C</creatorcontrib><title>Oral tolerance as therapy for experimental autoimmune encephalomyelitis and multiple sclerosis: Demonstration of T cell anergy</title><title>Immunology and cell biology</title><addtitle>Immunol Cell Biol</addtitle><description>Experimental autoimmune encephalomyelitis (EAE) is an important model for developing therapies for multiple sclerosis (MS). The oral administration of the central nervous system antigen, myelin basic protein (MBP), to Lewis rats and susceptible mouse strains prior to MBP immunization prevents the induction of EAE. Clinical trials administering myelin orally to MS patients have met with only partial success, and thus require that oral tolerance be further studied to improve this treatment strategy. Clonal anergy, clonal deletion, immune deviation from Th1 to Th2 T cell subsets, and active suppression by TGF‐β‐secreting T cells have all been implicated as possible mechanisms in oral tolerance. Which mechanism predominates depends on antigen dosage, frequency of feeding, and timing of antigen administration. In this study, we have characterized T cells derived from MBP‐fed rats and determined the level of their unresponsiveness. Myelin basic protein‐specific T cells are indeed present although in reduced numbers in lymphoid tissue of orally tolerized animals. Following several cell divisions in the presence of IL‐2, these MBP‐specific T cells undergo a dramatic reversal of unresponsiveness, proliferate in response to MBP and are capable of transferring EAE. These results support clonal anergy as an important mechanism for oral tolerance. Recent developments in clinical trials of oral tolerance are described.</description><subject>Administration, Oral</subject><subject>anergy</subject><subject>Animals</subject><subject>Cells, Cultured</subject><subject>Clonal Anergy - immunology</subject><subject>Cytokines - secretion</subject><subject>Encephalomyelitis, Autoimmune, Experimental - immunology</subject><subject>experimental autoimmune encephalomyelitis</subject><subject>Female</subject><subject>Guinea Pigs</subject><subject>Immune Tolerance - immunology</subject><subject>Male</subject><subject>multiple sclerosis</subject><subject>Multiple Sclerosis - immunology</subject><subject>Myelin Basic Protein - administration &amp; dosage</subject><subject>Myelin Basic Protein - immunology</subject><subject>oral tolerance</subject><subject>Phenotype</subject><subject>Rats</subject><subject>Rats, Inbred Lew</subject><subject>T cell</subject><subject>T-Lymphocytes - immunology</subject><subject>T-Lymphocytes - secretion</subject><subject>Tuberculin - administration &amp; dosage</subject><subject>Tuberculin - immunology</subject><issn>0818-9641</issn><issn>1440-1711</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqNkcFu3CAQhlHVKN2kfYRKnHqzC4sx0EvVbts0UqJckjPCeNywwsY1WFlf-uzB3VWu7QnEfPMz8CGEKSkpqeqP-5JWFSmooLSkSsmSEEHr8vAKbV4Kr9GGSCoLVVf0DbqIcU8ytZXsHJ0rzpkQaoP-3E3G4xQ8TGawgE3E6THvxwV3YcJwGGFyPQwpU2ZOwfX9PACGzI6Pxod-Ae-Si9gMLe5nn9zoAUeb80J08RP-Bn0YYppMcmHAocP32ILPYQNMv5a36KwzPsK703qJHn58v9_9LG7urq53X24Ky5RQhaGtErUkRNqOdKQ1pBIWOJjGcs6pNUSCbS3jXKiqqhrgtmkbbu1WbtumZewSfTjmjlP4PUNMundxnSOPEeaohZJEsZr_E6Q1E4opmUF5BG1-aJyg02P-KDMtmhK9OtJ7varQqwq9OtJ_HelDbn1_umNuemhfGk9Scv3zsf7kPCz_nauvb3df1wPFngGJ6qRX</recordid><startdate>199802</startdate><enddate>199802</enddate><creator>Jewell, Scott D</creator><creator>Gienapp, Ingrid E</creator><creator>Cox, Karen L</creator><creator>Whitacre, Caroline C</creator><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>199802</creationdate><title>Oral tolerance as therapy for experimental autoimmune encephalomyelitis and multiple sclerosis: Demonstration of T cell anergy</title><author>Jewell, Scott D ; Gienapp, Ingrid E ; Cox, Karen L ; Whitacre, Caroline C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3979-a1d9768008cf0f0da047ce5eabc5551ca08ecdc35579444be5cbdb5cc282dbd33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Administration, Oral</topic><topic>anergy</topic><topic>Animals</topic><topic>Cells, Cultured</topic><topic>Clonal Anergy - immunology</topic><topic>Cytokines - secretion</topic><topic>Encephalomyelitis, Autoimmune, Experimental - immunology</topic><topic>experimental autoimmune encephalomyelitis</topic><topic>Female</topic><topic>Guinea Pigs</topic><topic>Immune Tolerance - immunology</topic><topic>Male</topic><topic>multiple sclerosis</topic><topic>Multiple Sclerosis - immunology</topic><topic>Myelin Basic Protein - administration &amp; dosage</topic><topic>Myelin Basic Protein - immunology</topic><topic>oral tolerance</topic><topic>Phenotype</topic><topic>Rats</topic><topic>Rats, Inbred Lew</topic><topic>T cell</topic><topic>T-Lymphocytes - immunology</topic><topic>T-Lymphocytes - secretion</topic><topic>Tuberculin - administration &amp; dosage</topic><topic>Tuberculin - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jewell, Scott D</creatorcontrib><creatorcontrib>Gienapp, Ingrid E</creatorcontrib><creatorcontrib>Cox, Karen L</creatorcontrib><creatorcontrib>Whitacre, Caroline C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Immunology and cell biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jewell, Scott D</au><au>Gienapp, Ingrid E</au><au>Cox, Karen L</au><au>Whitacre, Caroline C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oral tolerance as therapy for experimental autoimmune encephalomyelitis and multiple sclerosis: Demonstration of T cell anergy</atitle><jtitle>Immunology and cell biology</jtitle><addtitle>Immunol Cell Biol</addtitle><date>1998-02</date><risdate>1998</risdate><volume>76</volume><issue>1</issue><spage>74</spage><epage>82</epage><pages>74-82</pages><issn>0818-9641</issn><eissn>1440-1711</eissn><abstract>Experimental autoimmune encephalomyelitis (EAE) is an important model for developing therapies for multiple sclerosis (MS). The oral administration of the central nervous system antigen, myelin basic protein (MBP), to Lewis rats and susceptible mouse strains prior to MBP immunization prevents the induction of EAE. Clinical trials administering myelin orally to MS patients have met with only partial success, and thus require that oral tolerance be further studied to improve this treatment strategy. Clonal anergy, clonal deletion, immune deviation from Th1 to Th2 T cell subsets, and active suppression by TGF‐β‐secreting T cells have all been implicated as possible mechanisms in oral tolerance. Which mechanism predominates depends on antigen dosage, frequency of feeding, and timing of antigen administration. In this study, we have characterized T cells derived from MBP‐fed rats and determined the level of their unresponsiveness. Myelin basic protein‐specific T cells are indeed present although in reduced numbers in lymphoid tissue of orally tolerized animals. Following several cell divisions in the presence of IL‐2, these MBP‐specific T cells undergo a dramatic reversal of unresponsiveness, proliferate in response to MBP and are capable of transferring EAE. These results support clonal anergy as an important mechanism for oral tolerance. Recent developments in clinical trials of oral tolerance are described.</abstract><cop>United States</cop><pub>Nature Publishing Group</pub><pmid>9553779</pmid><doi>10.1046/j.1440-1711.1998.00716.x</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0818-9641
ispartof Immunology and cell biology, 1998-02, Vol.76 (1), p.74-82
issn 0818-9641
1440-1711
language eng
recordid cdi_proquest_miscellaneous_79809365
source Wiley-Blackwell Read & Publish Collection
subjects Administration, Oral
anergy
Animals
Cells, Cultured
Clonal Anergy - immunology
Cytokines - secretion
Encephalomyelitis, Autoimmune, Experimental - immunology
experimental autoimmune encephalomyelitis
Female
Guinea Pigs
Immune Tolerance - immunology
Male
multiple sclerosis
Multiple Sclerosis - immunology
Myelin Basic Protein - administration & dosage
Myelin Basic Protein - immunology
oral tolerance
Phenotype
Rats
Rats, Inbred Lew
T cell
T-Lymphocytes - immunology
T-Lymphocytes - secretion
Tuberculin - administration & dosage
Tuberculin - immunology
title Oral tolerance as therapy for experimental autoimmune encephalomyelitis and multiple sclerosis: Demonstration of T cell anergy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T09%3A47%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oral%20tolerance%20as%20therapy%20for%20experimental%20autoimmune%20encephalomyelitis%20and%20multiple%20sclerosis:%20Demonstration%20of%20T%20cell%20anergy&rft.jtitle=Immunology%20and%20cell%20biology&rft.au=Jewell,%20Scott%20D&rft.date=1998-02&rft.volume=76&rft.issue=1&rft.spage=74&rft.epage=82&rft.pages=74-82&rft.issn=0818-9641&rft.eissn=1440-1711&rft_id=info:doi/10.1046/j.1440-1711.1998.00716.x&rft_dat=%3Cproquest_cross%3E79809365%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3979-a1d9768008cf0f0da047ce5eabc5551ca08ecdc35579444be5cbdb5cc282dbd33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16379398&rft_id=info:pmid/9553779&rfr_iscdi=true